Intermediate of rivastigmine, preparation and application thereof

The invention discloses a new making method of carbalatin as Alzheimer's disease drug and application, which is N, N-ethyl methyl-amino aminic acid 3-(1-methylamino ethyl) phenyl ester (II). The method improves receiving rate and product quality effectively, which is fit industrial manufacturin...

Full description

Saved in:
Bibliographic Details
Main Author CHAOJUN,FU TANG
Format Patent
LanguageEnglish
Published 15.08.2007
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention discloses a new making method of carbalatin as Alzheimer's disease drug and application, which is N, N-ethyl methyl-amino aminic acid 3-(1-methylamino ethyl) phenyl ester (II). The method improves receiving rate and product quality effectively, which is fit industrial manufacturing.
Bibliography:Application Number: CN2007167343